Sustaining Innovation Analyst Day

Investor presentations

  1. Home
  2. Investors
  3. Financial results and events
  4. Investor presentations

2018

IR conference call on Odyssey Outcomes
March 10, 2018

IR conference call on Odyssey Outcomes

Sanofi and Regeneron conference call for the financial community on the results of the ODYSSEY OUTCOMES study.
IR call on the acquisition of Ablynx
January 29, 2018

IR call on the acquisition of Ablynx

Sanofi hosted a conference call & webcast for the financial community to present the acquisition of Ablynx.
IR call on the acquisition of Bioverativ Inc.
January 22, 2018

IR call on the acquisition of Bioverativ Inc.

Sanofi hosted a conference call & webcast for the financial community to present the acquisition of Bioverativ Inc.

2017

Sustaining Innovation Analyst Day
December 13, 2017

Sustaining Innovation Analyst Day

Sanofi organized an analyst meeting to discuss Sanofi’s R&D strategy and development pipeline.
Dupixent® FDA approval call
March 28, 2017

Dupixent® FDA approval call

Sanofi and Regeneron hosted a conference call following the approval of Dupixent® in the U.S.

2016

IR thematic call on dupilumab
October 1, 2016

IR thematic call on dupilumab

Sanofi and Regeneron hosted a conference call focusing on dupilumab.
IR thematic call – Building global leadership in Consumer Healthcare
June 27, 2016

IR thematic call – Building global leadership in Consumer Healthcare

Sanofi organized a conference call following the signing of contracts with Boehringer Ingelheim.

2015

IR thematic call on sarilumab
November 9, 2015

IR thematic call on sarilumab

Sanofi and Regeneron hosted a conference call on sarilumab.
Meet Sanofi Management
November 6, 2015

Meet Sanofi Management

Sanofi organized a Meet Management Seminar focusing on its strategic roadmap 2020.
IR thematic call on Praluent® FDA approval
July 24, 2015

IR thematic call on Praluent® FDA approval

Sanofi and Regeneron hosted a conference call on the Praluent® FDA approval in the U.S.
IR thematic call on Diabetes
June 9, 2015

IR thematic call on Diabetes

Sanofi and Regeneron hosted a conference call on the Praluent® FDA approval in the U.S.

2014

IR thematic seminar on New Medicines
November 20, 2014

IR thematic seminar on New Medicines

Sanofi hosted an IR Thematic Seminar on New Medicines.
IR thematic call with Serge Weinberg
October 29, 2014

IR thematic call with Serge Weinberg

Sanofi held a conference call with Serge Weinberg for the financial community.
IR thematic call on alirocumab
September 2, 2014

IR thematic call on alirocumab

Sanofi and Regeneron hosted an IR Thematic Conference Call focusing on alirocumab during the European Society of Cardiology Congress in Barcelona.
TIR thematic call on Diabetes
June 16, 2014

IR thematic call on Diabetes

Sanofi hosted a Thematic Conference Call on Diabetes in connection with the American Diabetes Association's Scientific Sessions.
IR thematic call on alirocumab
March 31, 2014

IR thematic call on alirocumab

Sanofi and Regeneron hosted an IR Thematic Conference Call focusing on alirocumab during the American College of Cardiology Annual Meeting.

2013

IR thematic call on Multiple Sclerosis
October 3, 2013

IR thematic call on Multiple Sclerosis

Sanofi hosted a conference call during the European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting.
IR thematic call on Diabetes
June 24, 2013

IR thematic call on Diabetes

Sanofi organized a conference call during the American Diabetes Association Annual Meeting to provide an update for its diabetes business.